SaO039RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (CONESTAT ALFA) IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN HIGH-RISK PATIENTS (PROTECT): A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND SINGLE-CENTER TRIAL. (13th June 2019) - Panagiotou, Anneza; Moser, Stephan; Breidthardt, Tobias; Heijnen, Ingmar; Fahrni, Gregor; Kaiser, Christoph; Bonati, Leo; Trendelenburg, Marten; Jeger, Raban; Osthoff, Michael